Corbus Pharmaceuticals Holdings (CRBP) Change in Accured Expenses (2013 - 2025)
Corbus Pharmaceuticals Holdings' Change in Accured Expenses was $4.92 million in Q3 2025, compared with -$3.33 million a year earlier and up 181.6% from the prior quarter.
Powered by 
Analysis
Corbus Pharmaceuticals Holdings (CRBP) Change in Accured Expenses (2013 - 2025) Analysis & Trends
On a trailing twelve-month basis, Corbus Pharmaceuticals Holdings' Change in Accured Expenses was $5.4 million through Sep 30, 2025; for FY2024, it was -$5.61 million.
- In earlier years, Change in Accured Expenses was $5.03 million in FY2023, -$4.09 million in FY2022, -$11.91 million in FY2021 and -$400,766 in FY2020.
- The Q3 2025 figure marks the highest quarterly Change in Accured Expenses since Q1 2019.
- Per Business Quant data, CRBP's Change in Accured Expenses in the three quarters before Q3 2025 was $1.75 million (Q2 2025), $476,000 (Q1 2025) and -$1.74 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 49.84 Mn | -466.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 4.92 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Mar 31, 2025 | 476,000.00 |
| Dec 31, 2024 | -1.74 Mn |
| Sep 30, 2024 | -3.33 Mn |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | -1.63 Mn |
| Dec 31, 2023 | 3.48 Mn |
| Sep 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | -49,050.00 |
| Mar 31, 2023 | 469,050.00 |
| Dec 31, 2022 | 1.17 Mn |
| Sep 30, 2022 | 117,416.00 |
| Jun 30, 2022 | -779,984.00 |
| Mar 31, 2022 | -4.60 Mn |
| Dec 31, 2021 | -3.52 Mn |
| Sep 30, 2021 | -1.47 Mn |
| Jun 30, 2021 | -2.65 Mn |
| Mar 31, 2021 | -4.26 Mn |
| Dec 31, 2020 | -6.59 Mn |
API Access
Corbus Pharmaceuticals Holdings Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CRBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "CRBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CRBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();